Cumulative Helicobacter pylori eradication rates in Slovenia in the year 2008
Abstract
Background: h e aim of the study was to examine cumulative Helicobacter pylori eradication rates in Slovenia in the year 2008 that can be achieved in clinical practice by clasic i rst and second regimens suggested by Maastricht recommendations and third line empirical regimens. Methods: We performed cross sectional study that included 500 consecutive patients, who underwent urea breath test at er Helicobacter pylori eradication regimens in AM DC Rogaška in the period from January to September 2008.We analysed eradication rates at er OMC regimen, 7 days (omeprazole, metronidazole, clarithromycin), OAC regimen, 7 days (omeprazole, amoxicillin, clarithromycin), BMTO regimen, 14 days (colloid bismuth subcitrate, metronidazole, oxytetracycline, omeprazole) and OA regimen, 14 days (omeprazole, amoxicillin). Results: Total 308 patients received OMC regimen with eradication rate 78.6 % (95 % CI 76.3%–80.9%). Total 80 patients received OAC regimen with eradication rate 80 % (95 % CI 75.6 %–84.4 %). At er failure of the i rst regimen, they received the opposite i rst-line regimen. In the case of eradication failure, 23 patients received BMTO regimen as a third-line therapy with eradication rate 82.6 % and 14 patients received OA regimen with eradication rate 64.3 %. Nine of 388 patients who started Helicobacter pylori eradication treatment in our study remained positive at er they received all the available therapeutical regimens (2,3 %). Conclusions. Cumulative Helicobacter pylori eradication rate in Slovenia in the year 2008 is still very high–97.7 %. h ese results are comparable with the results in other European countries.
Downloads
References
The Author transfers to the Publisher (Zdravniški vestnik/Slovenian Medical Journal) all economic copyrights following form Article 22 of the Slovene Copyright and Related Rights Act (ZASP), including the right of reproduction, the right of distribution, the rental right, the right of public performance, the right of public transmission, the right of public communication by means of phonograms and videograms, the right of public presentation, the right of broadcasting, the right of rebroadcasting, the right of secondary broadcasting, the right of communication to the public, the right of transformation, the right of audiovisual adaptation and all other rights of the author according to ZASP.
The aforementioned rights are transferred non-exclusively, for an unlimited number of editions, for the term of the statutory
The Author can make use of his work himself or transfer subjective rights to others only after 3 months from date of first publishing in the journal Zdravniški vestnik/Slovenian Medical Journal.
The Publisher (Zdravniški vestnik/Slovenian Medical Journal) has the right to transfer the rights, acquired parties without explicit consent of the Author.
The Author consents that the Article be published under the Creative Commons BY-NC 4.0 (attribution-non-commercial) or comparable licence.